A carregar...

Naming Convention, Interchangeability, and Patient Interest in Biosimilars

Although biosimilars may offer cost savings over their comparable biologics, use of biosimilars in the United States remains relatively low. This study investigates two barriers to uptake of biosimilars in the United States. First, the U.S. Food and Drug Administration requires that four-letter suff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Spectr
Main Authors: Socal, Mariana P., Garrett, Jace B., Tayler, William B., Bai, Ge, Anderson, Gerard F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7428664/
https://ncbi.nlm.nih.gov/pubmed/32848349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds19-0065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!